These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 17326359
1. Topographic centration of ablation after LASIK for myopia using the CustomVue VISX S4 excimer laser. Ou JI, Manche EE. J Refract Surg; 2007 Feb; 23(2):193-7. PubMed ID: 17326359 [Abstract] [Full Text] [Related]
2. CustomVue laser in situ keratomileusis for myopia and myopic astigmatism using the Visx S4 excimer laser: Efficacy, predictability, and safety. Partal AE, Manche EE. J Cataract Refract Surg; 2006 Mar; 32(3):475-9. PubMed ID: 16631061 [Abstract] [Full Text] [Related]
4. Ablation centration in myopic laser in situ keratomileusis. comparing the Visx S3 ActiveTrak and the Visx S2. Giaconi JA, Manche EE. J Cataract Refract Surg; 2003 Aug; 29(8):1522-9. PubMed ID: 12954299 [Abstract] [Full Text] [Related]
5. Wavefront-guided laser in situ keratomileusis with the Alcon CustomCornea and the VISX CustomVue: three-month results. Awwad ST, El-Kateb M, Bowman RW, Cavanagh HD, McCulley JP. J Refract Surg; 2004 Aug; 20(5):S606-13. PubMed ID: 15523984 [Abstract] [Full Text] [Related]
6. Topographic- and wavefront-guided customized ablations with the NIDEK-EC5000CXII in LASIK for myopia. Kermani O, Schmiedt K, Oberheide U, Gerten G. J Refract Surg; 2006 Oct; 22(8):754-63. PubMed ID: 17061712 [Abstract] [Full Text] [Related]
7. Prospective randomized trial of wavefront-guided laser in situ keratomileusis with the CustomCornea and CustomVue laser systems. Moshirfar M, Espandar L, Meyer JJ, Tanner JR, Holz HA. J Cataract Refract Surg; 2007 Oct; 33(10):1727-33. PubMed ID: 17889767 [Abstract] [Full Text] [Related]
8. Zernike versus Fourier treatment tables for myopic patients having CustomVue wavefront laser in situ keratomileusis with the S4 excimer laser. Ou JI, Manche EE. J Cataract Refract Surg; 2007 Apr; 33(4):654-7. PubMed ID: 17397739 [Abstract] [Full Text] [Related]
9. Wavefront-guided LASIK for myopia using the LADAR CustomCornea and the VISX CustomVue. Awwad ST, Bowman RW, Cavanagh HD, McCulley JP. J Refract Surg; 2007 Jan; 23(1):26-38. PubMed ID: 17269241 [Abstract] [Full Text] [Related]
11. A comparison of induced astigmatism in conventional and wavefront-guided myopic LASIK using LADARVision4000 and VISX S4 platforms. Awwad ST, Haithcock KK, Oral D, Bowman RW, Cavanagh HD, McCulley JP. J Refract Surg; 2005 Jan; 21(6):S792-8. PubMed ID: 16329382 [Abstract] [Full Text] [Related]
12. Hyperopic laser in situ keratomileusis: primary and secondary treatments are safe and effective. Choi RY, Wilson SE. Cornea; 2001 May; 20(4):388-93. PubMed ID: 11333326 [Abstract] [Full Text] [Related]
13. Wavefront-guided LASIK with the NIDEK NAVEX platform for the correction of myopia and myopic astigmatism with 6-month follow-up. Venter J. J Refract Surg; 2005 May; 21(5 Suppl):S640-5. PubMed ID: 16212296 [Abstract] [Full Text] [Related]
14. A retrospective comparison of LASIK outcomes for myopia and myopic astigmatism with conventional NIDEK versus wavefront-guided VISX and Alcon platforms. Dougherty PJ, Bains HS. J Refract Surg; 2008 Nov; 24(9):891-6. PubMed ID: 19044229 [Abstract] [Full Text] [Related]
15. Femtosecond laser versus mechanical keratome LASIK for myopia. Montés-Micó R, Rodríguez-Galietero A, Alió JL. Ophthalmology; 2007 Jan; 114(1):62-8. PubMed ID: 17070593 [Abstract] [Full Text] [Related]
16. Four-year visual, refractive, and contrast sensitivity outcomes after wavefront-guided myopic LASIK using an advanced excimer laser platform. Shaheen MS, Massoud TH, Ezzeldin H, Khalifa MA. J Refract Surg; 2013 Dec; 29(12):816-22. PubMed ID: 24168789 [Abstract] [Full Text] [Related]
17. Wavefront-guided LASIK with the Zyoptix 3.1 system for the correction of myopia and compound myopic astigmatism with 1-year follow-up: clinical outcome and change in higher order aberrations. Kohnen T, Bühren J, Kühne C, Mirshahi A. Ophthalmology; 2004 Dec; 111(12):2175-85. PubMed ID: 15582071 [Abstract] [Full Text] [Related]